Barclays
CELG

Barclays’s Celgene Corp CELG Stock Holding History

Barclays’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-212,400
Closed -$21.1M – 7236
2019
Q3 		$21.1M Sell
212,400
-35,100
-14% -$3.34M 0.01% 855
2019
Q2 		$22.9M Sell
247,500
-961,500
-80% -$91.3M 0.01% 844
2019
Q1 		$114M Buy
1,209,000
+545,000
+82% +$47.7M 0.08% 203
2018
Q4 		$42.6M Buy
664,000
+91,900
+16% +$6.78M 0.03% 434
2018
Q3 		$51.2M Sell
572,100
-336,200
-37% -$29.7M 0.04% 407
2018
Q2 		$72.1M Buy
908,300
+440,600
+94% +$36.6M 0.06% 259
2018
Q1 		$41.7M Buy
467,700
+145,400
+45% +$14M 0.03% 489
2017
Q4 		$33.6M Sell
322,300
-258,000
-44% -$29.1M 0.03% 561
2017
Q3 		$84.6M Buy
580,300
+146,500
+34% +$20M 0.09% 184
2017
Q2 		$56.3M Buy
433,800
+44,300
+11% +$5.43M 0.06% 248
2017
Q1 		$48.5M Sell
389,500
-66,300
-15% -$7.93M 0.05% 258
2016
Q4 		$52.8M Buy
455,800
+25,100
+6% +$2.8M 0.06% 262
2016
Q3 		$45M Buy
430,700
+95,400
+28% +$10.3M 0.05% 278
2016
Q2 		$33.1M Buy
335,300
+60,400
+22% +$6.25M 0.04% 346
2016
Q1 		$27.5M Sell
274,900
-87,000
-24% -$8.96M 0.04% 383
2015
Q4 		$43.1M Sell
361,900
-201,100
-36% -$23.3M 0.05% 324
2015
Q3 		$60.8M Buy
563,000
+252,400
+81% +$31.3M 0.07% 228
2015
Q2 		$35.7M Sell
310,600
-4,600
-1% -$526K 0.04% 410
2015
Q1 		$36.2M Sell
315,200
-229,700
-42% -$27.4M 0.04% 422
2014
Q4 		$60.5M Buy
544,900
+200,800
+58% +$21.2M 0.06% 289
2014
Q3 		$32.3M Sell
344,100
-63,200
-16% -$5.7M 0.03% 499
2014
Q2 		$34.6M Sell
407,300
-229,300
-36% -$17.4M 0.04% 434
2014
Q1 		$44.2M Buy
636,600
+349,800
+122% +$27.7M 0.05% 335
2013
Q4 		$24.1M Sell
286,800
-255,600
-47% -$20.2M 0.02% 660
2013
Q3 		$41.8M Sell
542,400
-43,800
-7% -$3.07M 0.05% 355
2013
Q2 		$34.3M Buy
+586,200
New +$35.3M 0.04% 383

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Barclays's CELG Position: Q4 2019 in Review

Barclays sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 4,134,829 shares — an estimated $411M sold.

Barclays first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $411M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Barclays reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Barclays sold 4,134,829 Celgene Corp shares in Q4 2019, an estimated $411M.
  • Barclays first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Barclays's Celgene Corp position peaked at $411M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.